Assessment of Hsp90β-selective inhibitor safety and on-target effectsTyelor S. Reynolds(University of Notre Dame), Brian S. J. Blagg(University of Notre Dame)Scientific ReportsJanuary 29, 202510.1038/s41598-025-86647-yCited by 10SaveCiteExport RISWatch citationsRelated PapersIntegrative Multi-Omics Analyses Reveal Mechanisms of Resistance to Hsp90β-Selective Inhibition|Cancers|2025|2